文献速递腹部技术与安全US

多参数超声识别代谢功能障碍相关脂肪性肝炎:一项前瞻性多中心研究

Multiparametric US for Identifying Metabolic Dysfunction-associated Steatohepatitis: A Prospective Multicenter Study.
PubMed 文献 · Radiology · 2024-01-01

该前瞻性横断面多中心研究纳入424例代谢功能障碍相关脂肪肝病(MAFLD)成人,评估衰减成像(ATI)与二维剪切波弹性成像(2D SWE)预测代谢功能障碍相关脂肪性肝炎(MASH)的能力。联合衰减系数(AC)、丙氨酸氨基转移酶(ALT)和国际标准化比值(INR)的模型在训练组和验证组预测MASH的AUC分别为0.85和0.77。

要点

  • 联合AC、ALT和INR的模型在训练组预测MASH的AUC为0.85,验证组为0.77。
  • AC与MASH独立相关(OR 3.32,95%CI 1.94-5.71,P<.001)。
  • 糖尿病亚组与非糖尿病亚组AUC分别为0.83和0.81,乙肝亚组与非乙肝亚组分别为0.82和0.79。

核心结论

  • 联合AC、ALT和INR的模型对MAFLD患者预测MASH显示出良好的判别能力。

研究设计与样本

  • 前瞻性横断面多中心研究,纳入2020年9月至2022年6月中国12家三级医院的424例连续MAFLD成人,均行多参数超声(ATI和2D SWE)及肝活检,按6:4比例分为训练组和验证组。

关键影像表现/征象

  • AC(OR 3.32,95%CI 1.94-5.71;P<.001)与MASH独立相关。
  • ALT(OR 4.42,95%CI 1.78-10.94;P=.001)与MASH独立相关。
  • INR(OR 0.59,95%CI 0.37-0.95;P=.03)与MASH独立相关。

诊断标准与关键数值

  • 联合模型(AC、ALT和INR)预测MASH的AUC在训练组为0.85(95%CI 0.79-0.91),验证组为0.77(95%CI 0.69-0.85)。
  • 糖尿病亚组预测MASH的AUC为0.83(95%CI 0.72-0.94),非糖尿病亚组为0.81(95%CI 0.75-0.87)。
  • 乙肝亚组预测MASH的AUC为0.82(95%CI 0.74-0.90),非乙肝亚组为0.79(95%CI 0.71-0.87)。

临床应用与阅片要点

  • 在MAFLD患者中,可考虑联合AC、ALT和INR构建模型辅助预测MASH(作者结论)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Noninvasive evaluation of metabolic dysfunction-associated fatty liver disease (MAFLD) with multiparametric US is essential, but multicenter studies are lacking. Purpose To evaluate the ability of multiparametric US with attenuation imaging (ATI) and two-dimensional (2D) shear-wave elastography (SWE) for predicting metabolic dysfunction-associated steatohepatitis (MASH) in participants with MAFLD, regardless of hepatitis B virus infection status. Materials and Methods This prospective cross-sectional multicenter study of consecutive adults with MAFLD who underwent multiparametric US with ATI and 2D SWE, as well as liver biopsy, from September 2020 to June 2022 was conducted in 12 tertiary hospitals in China. Multivariable logistic regression was performed to assess risk factors associated with MASH. Area under the receiver operating characteristic curve (AUC) analysis was used to evaluate diagnostic performance in predicting MASH in training and validation groups (6:4 ratio of participants), and for a post hoc subgroup analysis of hepatitis B virus infection and diabetes. Results A total of 424 participants (median age, 47 years; IQR, 34-59 years; 244 male) were evaluated, including 332 participants (78%) with MASH and 92 (22%) without. Attenuation coefficient (AC) (odds ratio [OR], 3.32 [95% CI: 1.94, 5.71]; P < .001), alanine aminotransferase (ALT) level (OR, 4.42 [95% CI: 1.78, 10.94]; P = .001), and international normalized ratio (INR) (OR, 0.59 [95% CI: 0.37, 0.95]; P = .03) were independently associated with MASH. A combined model (AC, ALT, and INR) had AUCs of 0.85 (95% CI: 0.79, 0.91) and 0.77 (95% CI: 0.69, 0.85) for predicting MASH in the training and validation groups, respectively. AUC values for the subgroups with and without diabetes were 0.83 (95% CI: 0.72, 0.94) and 0.81 (95% CI: 0.75, 0.87) and for the subgroups with and without hepatitis B were 0.82 (95% CI: 0.74, 0.90) and 0.79 (95% CI: 0.71, 0.87), respectively. Conclusion A model combining AC, ALT level, and INR showed good discrimination ability for predicting MASH in participants with MAFLD. Clinical trial registration no. NCT04551716 © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Reuter in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Liu F, Bi M, Jing X, et al. Multiparametric US for Identifying Metabolic Dysfunction-associated Steatohepatitis: A Prospective Multicenter Study. Radiology. 2024. PMID: 38501954. doi:10.1148/radiol.232416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。